# Enicepatide Side Effects: What Studies and Users Report

Source: https://pepvault.app/peptides/enicepatide/side-effects

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Enicepatide](https://pepvault.app/peptides/enicepatide) Side effects

Peptide questions · Enicepatide

# Enicepatide side effects: what studies and users report

Reviewed November 2026 Evidence: Moderate [Published by PepVault](https://pepvault.app/guides/how-we-research)

The side effects most commonly reported for enicepatide are nausea, constipation and diarrhea, among 4 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: enicepatide has no label: it is still in trials.

## What is commonly reported with enicepatide

- Nausea
- Constipation
- Diarrhea
- Vomiting

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for

| Effect | Also listed for (of 24) |
| --- | --- |
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Constipation | 13: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 9 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track enicepatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which enicepatide side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Every effect on enicepatide’s list also appears for at least one other metabolic & GLP-1 compound, so nothing on it is enicepatide’s own.

## More on enicepatide

### Enicepatide

- [Enicepatide: the full reference](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/enicepatide-10mg)

### Studies

- [Enicepatide: -4.7% to -8.0% body weight change by day 29 in phase 1](https://pepvault.app/research/enicepatide-chakravarthy-2026)
- [The study on the research page](https://pepvault.app/research#enicepatide)

### Compared with

- [Tirzepatide vs Enicepatide](https://pepvault.app/peptides/compare/tirzepatide-vs-enicepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Enicepatide questions

- [Enicepatide: half-life](https://pepvault.app/peptides/enicepatide/half-life)
- [Enicepatide: how long it takes to work](https://pepvault.app/peptides/enicepatide/how-long-to-work)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Incretin](https://pepvault.app/glossary/incretin)

## What the enicepatide safety notes say

> The library’s safety note
>
> Enicepatide has no label: it is still in trials. In the 48-week obesity phase 2 trial, most side effects were GI (nausea, constipation, diarrhea, vomiting) and mild to moderate, in line with the incretin class; 5.9% on enicepatide stopped for side effects vs 1.3% on placebo, and serious events were low and not dose-related, with no grade 4 or 5 events. In the diabetes phase 2 trial, 2.0% stopped for side effects vs 0% on placebo. It is a GLP-1 drug, so the class warnings in GLP-1 labels (including pancreatitis, gallbladder disease and the rodent thyroid C-cell finding) are the ones to read. These are trial findings to review with your clinician.

> The library’s interaction note
>
> No interaction studies have been published. GLP-1 drugs slow stomach emptying, which can change how oral medicines are absorbed. It is a GLP-1 drug itself, so it is not stacked with another one. Roche plans to test it with its amylin drug petrelintide. With insulin or a sulfonylurea, discuss glucose monitoring with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Where the enicepatide reports come from

The library rates the evidence on enicepatide as moderate: animal studies plus some human data.

Of the library’s 7 research notes on enicepatide, 5 rest on randomized trials, 1 on clinical data and 1 on community reports.

Our 1 study page on enicepatide: 1 randomized trial.

So enicepatide has controlled trials in people to set its listed effects against.

## What our enicepatide study pages report on safety

### Enicepatide: -4.7% to -8.0% body weight change by day 29 in phase 1

Randomized trial, human, 2026: Most side effects were mild or moderate, and the safety pattern matched other incretin-based medicines. This is an early human result for enicepatide: weight loss and better blood sugar over 4 weeks, with side effects similar to other drugs in its class.

- [Read the study page: Enicepatide: -4.7% to -8.0% body weight change by day 29 in phase 1](https://pepvault.app/research/enicepatide-chakravarthy-2026)

## Questions people ask

### What are the side effects of enicepatide?

The side effects most commonly reported for enicepatide are nausea, constipation and diarrhea, among 4 the library lists; the library’s evidence on it includes controlled trials in people.

### Do enicepatide’s side effects come from human studies?

The library rates the evidence on enicepatide as moderate, and the library’s evidence on it includes controlled trials in people.

### Which enicepatide side effects are its own?

None: each effect the library lists for enicepatide is listed for at least one other metabolic & GLP-1 compound too.

### Does enicepatide interact with other medicines?

The library’s interaction note on enicepatide begins: No interaction studies have been published.

## More on enicepatide

- [Enicepatide: the full library page](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)
- [Enicepatide: half-life](https://pepvault.app/peptides/enicepatide/half-life)
- [Enicepatide: how long it takes to work](https://pepvault.app/peptides/enicepatide/how-long-to-work)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track enicepatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track enicepatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on enicepatide

### Enicepatide

- [Enicepatide: the full reference](https://pepvault.app/peptides/enicepatide)
- [Enicepatide dose guide](https://pepvault.app/lab/dosage/enicepatide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/enicepatide-10mg)

### Studies

- [Enicepatide: -4.7% to -8.0% body weight change by day 29 in phase 1](https://pepvault.app/research/enicepatide-chakravarthy-2026)
- [The study on the research page](https://pepvault.app/research#enicepatide)

### Compared with

- [Tirzepatide vs Enicepatide](https://pepvault.app/peptides/compare/tirzepatide-vs-enicepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Enicepatide questions

- [Enicepatide: half-life](https://pepvault.app/peptides/enicepatide/half-life)
- [Enicepatide: how long it takes to work](https://pepvault.app/peptides/enicepatide/how-long-to-work)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Incretin](https://pepvault.app/glossary/incretin)

<!--promo-->

PepVault for iPhone

## Track enicepatide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Enicepatide

- [Enicepatide in the library](https://pepvault.app/peptides/enicepatide)
- [Enicepatide: half-life](https://pepvault.app/peptides/enicepatide/half-life)
- [Enicepatide: how long it takes to work](https://pepvault.app/peptides/enicepatide/how-long-to-work)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
